|
Contents
|
|
|
|
Glioblastoma
|
|
|
|
C. F. Classen, M. Warmuth-Metz, K. Papke,
A. Trotter, J. E. A. Wolff, S. Wagner
Late
response to radiochemotherapy in pediatric glioblastoma: report on two
patients treated according to HIT-GBM protocols
Pediatr
Hematol Oncol. 2006
Dec;23(8):631-7. DOI: 10.1080/08880010600951088
|
|
|
Glas M, Happold C, Rieger J, Wiewrodt D, Bähr O, Steinbach JP, Wick W,
Kortmann RD, Reifenberger G, Weller M, Herrlinger U
Long-Term
Survival of Patients With Glioblastoma Treated With Radiotherapy and
Lomustine Plus Temozolomide
J
Clin Oncol. 2009 Feb 2. [Epub ahead of print]
.JPG)
Abstract
|
|
Herrlinger U, Rieger J, Koch D, Loeser S, Blaschke
B, Kortmann RD, Steinbach JP, Hundsberger T, Wick W, Meyermann R, Tan TC, Sommer
C, Bamberg M, Reifenberger G, Weller M.
Phase II trial of lomustine plus temozolomide chemotherapy in addition to
radiotherapy in newly diagnosed glioblastoma: UKT-03.
J Clin Oncol. 2006 Sep 20;24(27):4412-7.
Abstract
|
| |
D. Reardon, H. Friedman, W. K. A. Yung, M. Brada, C. Conrad, J. Provenzale,
E. Jackson, H. Serajuddin, B. Chen, D. Laurent
A phase I/II trial of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis
inhibitor, in combination with either temozolomide or lomustine for patients
with recurrent glioblastoma multiforme (GBM)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1513
|
|
D.
Reardon, H. S. Friedman, W. K. A. Yung, M. Brada, C. Conrad, J. Provenzale,
E. F. Jackson, H. Serajuddin, D. Laurent, D. Reitsma
A
phase I trial of PTK787/ZK 222584 (PTK/ZK), an oral VEGF tyrosine kinase
inhibitor, in combination with either temozolomide or lomustine for patients
with recurrent glioblastoma multiforme (GBM)
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No. 412
|
|
|
Wick
W, Puduvalli VK, Chamberlain MC, van den Bent MJ, Carpentier AF, Cher LM,
Mason W, Weller M, Hong S, Musib L, Liepa AM, Thornton DE, Fine HA
Phase
III Study of Enzastaurin Compared With Lomustine in the Treatment of
Recurrent Intracranial Glioblastoma
J Clin Oncol.
2010 Feb 1. [Epub ahead of print]
Abstract
|
|
|
Gliomas
|
|
|
|
S.
Tafuto, R. Guarrasi, A. Tortoriello, F. Buzzi, P. Muto, R. Formato, P.
Comella, P. De Rosa, R. V. Iaffaioli, S. Quattrin
Temozolomide (TMZ) and lomustine
(CCNU) in high grade glioma (HGG) patients: Phase I study
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1577
|
|
|
Wolff JE, Berrak S, Koontz Webb SE, Zhang M
Nitrosourea efficacy in high-grade glioma: a survival gain analysis
summarizing 504 cohorts with 24193 patients
J Neurooncol. 2008 Feb 6; [Epub ahead of print]
Abstract
|
|
Recurrent
Tumors
|
|
|
|
Walbert
T, Gilbert MR, Groves MD, Puduvalli VK, Alfred Yung WK, Conrad CA, Bobustuc
GC, Colman H, Hsu SH, Nebiyou Bekele B, Qiao W, Levin VA.
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide
or lomustine for recurrent high-grade glioma
J Neurooncol. 2010 Jul 23;. [Epub ahead of print]
Abstract
|
|
|
Gliomatosis
Cerebri
|
|
|
|
|
Glas M, Bähr O, Felsberg J, Rasch K, Wiewrodt D, Schabet M, Simon M, Urbach
H, Steinbach JP, Rieger J, Fimmers R, Bamberg M, Nägele T, Reifenberger G,
Weller M, Herrlinger Md U, Group Of The German Cancer Society FT.
NOA-05
phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
Ann Neurol. 2011 May
11. [Epub ahead of print]
Abstract |
.gif) Related articles
|
|
|
Medulloblastoma
|
|
|
|
F.
Spreafico, M. Massimino, L. Gandola, S. Siena, G. Cefalo, E. Mazza, P.
Versari, G. Landonio, P. Pedrazzoli, F. Fossati-Bellani
Survival
results in adults treated for medulloblastoma
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
479
|
|
|
Metastatic
Tumors
|
|
|
|
Jane W. Marsh,
Maryann Donovan, Dennis R. Burholt, Lisa D. George and Paul L. Kornblith
Metastatic lung disease to the central nervous system: in
vitro response to
chemotherapeutic agents
Journal of Neuro-Oncology 66: 81–90, January
2004. (Abstract+)
|
|
